Deepinder Goyal’s ₹85,000 Temple Device Sparks Debate Over Science and Health Claims
A new wearable technology introduced by Zomato founder Deepinder Goyal has attracted considerable attention in India's technology and healthcare circles. Called Temple, the device is priced at ₹85,000 and is designed to monitor physiological signals associated with blood circulation near the head. However, what began as an ambitious technology project has turned into a debate involving doctors, scientific evidence, consumer expectations and the growing business of health-monitoring gadgets.
The controversy raises an important question: can a wearable device attached to the side of the head provide meaningful information about brain health, or are its capabilities being presented more confidently than current scientific evidence allows?
What Is Deepinder Goyal’s Temple Device?
Temple is a small, pill-shaped wearable designed to be attached near the temple, on the side of the head. Unlike conventional fitness trackers that are generally worn on the wrist, this device uses optical sensing technology to collect physiological information from the area where it is positioned.
The product is associated with Goyal's research interests in blood circulation, human physiology and ageing. One of its central features is a measurement called BrainFlow, which is intended to provide information about changes in blood flow and oxygenation.
The device also introduces another measurement called Entropy. According to the product's explanation, this score is intended to indicate how much physiological strain the body experiences while managing factors such as stress, physical activity, sleep quality and other daily influences.
The broader objective is to help users understand their body's condition beyond the conventional measurements offered by smartwatches and fitness bands.
However, the distinction between collecting a biological signal and accurately interpreting what that signal means is at the centre of the current debate.
Why Does the Device Cost ₹85,000?
Temple's reported price of ₹85,000 places it in the premium segment of the wearable technology market. Its pricing reflects the company's positioning of the product as a specialised health and performance monitoring device rather than an ordinary fitness tracker.
Goyal has defended the investment behind its development, stating that approximately $30 million has been spent on the project, including $20 million from his personal funds.
The device has attracted attention partly because of Goyal's reputation as an entrepreneur and his previous experience building large consumer technology businesses.
Nevertheless, a high development cost does not automatically establish a product's scientific accuracy or practical usefulness. Consumers need to evaluate what the device can reliably measure and whether those measurements provide information that can improve everyday decisions.
Why Are Doctors Questioning Temple?
The main criticism concerns whether a sensor placed outside the skull can accurately measure blood circulation inside the brain.
The device sits near the superficial temporal artery, which runs close to the skin. Doctors have questioned whether measurements collected from this location can represent cerebral blood flow accurately.
The brain has a complex network of arteries and smaller blood vessels supplying different regions. Blood circulation is regulated according to the body's requirements, and different brain regions may experience variations in blood flow.
Therefore, detecting changes in circulation at one external location does not automatically establish what is happening throughout the brain.
Medical professionals, including hepatologist Dr Cyriac Abby Philips, have publicly questioned the scientific basis of some of the product's claims.
The criticism is not necessarily about whether wearable technology can collect useful physiological information. Instead, it concerns whether the available evidence is sufficient to support the broader conclusions being associated with those measurements.
The Difference Between a Health Metric and a Medical Diagnosis
One important aspect of this controversy is the difference between wellness monitoring and medical diagnosis.
Modern wearable devices can collect information about heart rate, sleep patterns, physical activity and other physiological indicators. Such information may help individuals understand changes in their daily routines.
However, these measurements cannot automatically replace medical investigations.
For example, doctors use established diagnostic methods such as Transcranial Doppler ultrasound, CT angiography and MR angiography to investigate different aspects of cerebral circulation. Each technique has specific clinical applications and limitations.
A wearable device that measures a signal near the head would need appropriate scientific validation before its readings could be considered reliable indicators of conditions affecting the brain.
Temple is being positioned as a fitness and wellness product rather than a medical diagnostic device. Goyal has also clarified that distinction while defending the technology.
This is an important point for potential buyers. A wellness score should not be interpreted as proof that someone has good brain health or is free from neurological conditions.
Deepinder Goyal’s Response to the Criticism
Goyal has responded to questions raised by medical professionals and defended the company's approach to developing Temple.
He has highlighted the investment made in the project, its development journey and the availability of a 14-day return policy. He has also indicated that research publications and independent validation studies are expected as the product progresses.
His argument is that new technology can require years of development and testing before its capabilities are fully established.
However, critics believe that companies making health-related claims should provide convincing scientific evidence before asking consumers to pay premium prices.
The disagreement reflects a broader challenge in the technology industry: entrepreneurs often move quickly from research concepts to consumer products, while scientific validation requires carefully designed studies, independent examination and reproducible results.
Both innovation and scientific scrutiny are important, particularly when products deal with human health.
What Should Consumers Consider Before Buying?
The Temple controversy offers several useful lessons for people considering expensive wearable technology.
First, buyers should understand exactly what a product measures. A numerical score may look scientific, but its usefulness depends on how it is calculated and whether it has been independently validated.
Second, consumers should distinguish between company research and independent scientific studies. Research conducted by a product's development team can provide useful preliminary information, but independent verification is important for establishing reliability.
Third, celebrity endorsements and the involvement of successful entrepreneurs should not replace technical evaluation. A well-known personality using a product does not establish its medical effectiveness.
Finally, buyers should consider whether the information provided by an expensive device offers meaningful benefits compared with more affordable alternatives.
A Bigger Debate About the Future of Health Technology
The discussion surrounding Temple highlights the growing intersection of artificial intelligence, wearable technology, human biology and consumer healthcare.
There is genuine potential in developing devices that continuously monitor physiological changes outside traditional medical settings. Such innovations could eventually help researchers understand patterns associated with exercise, recovery, circulation and other aspects of human performance.
However, innovation must be accompanied by transparency and evidence.
For Temple, the next important step will be demonstrating how accurately its measurements work through well-designed, independently conducted research.
The Bottom Line
Deepinder Goyal's ₹85,000 Temple device represents an ambitious attempt to explore new possibilities in wearable health technology. Its unusual design and proposed measurements have generated interest, but questions about scientific accuracy and clinical relevance remain important.
Ultimately, the success of Temple will depend not simply on its price, technology or the reputation of its founder, but on whether independent research can establish that the information it provides is genuinely useful and reliable.
